Schedule 13G ownership disclosure

LA JOLLA PHARMACEUTICAL CO

Security class unavailable · CUSIP: 503459604

Event date: 2019-01-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-007512
Form type
SC 13G/A
Filer
LA JOLLA PHARMACEUTICAL CO
CIK
CIK 920465
Filed
Jan 11, 2019
Reporting period
Jan 08, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub